205 related articles for article (PubMed ID: 25288731)
1. Role of Erbin in ErbB2-dependent breast tumor growth.
Tao Y; Shen C; Luo S; Traoré W; Marchetto S; Santoni MJ; Xu L; Wu B; Shi C; Mei J; Bates R; Liu X; Zhao K; Xiong WC; Borg JP; Mei L
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4429-38. PubMed ID: 25288731
[TBL] [Abstract][Full Text] [Related]
2. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
3. ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor.
Borg JP; Marchetto S; Le Bivic A; Ollendorff V; Jaulin-Bastard F; Saito H; Fournier E; Adélaïde J; Margolis B; Birnbaum D
Nat Cell Biol; 2000 Jul; 2(7):407-14. PubMed ID: 10878805
[TBL] [Abstract][Full Text] [Related]
4. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
5. Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction.
Simeone L; Straubinger M; Khan MA; Nalleweg N; Cheusova T; Hashemolhosseini S
J Neurosci; 2010 May; 30(19):6620-34. PubMed ID: 20463225
[TBL] [Abstract][Full Text] [Related]
6. The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins.
Jaulin-Bastard F; Saito H; Le Bivic A; Ollendorff V; Marchetto S; Birnbaum D; Borg JP
J Biol Chem; 2001 May; 276(18):15256-63. PubMed ID: 11278603
[TBL] [Abstract][Full Text] [Related]
7. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
8. Novel mode of ligand recognition by the Erbin PDZ domain.
Birrane G; Chung J; Ladias JA
J Biol Chem; 2003 Jan; 278(3):1399-402. PubMed ID: 12444095
[TBL] [Abstract][Full Text] [Related]
9. Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95.
Huang YZ; Wang Q; Xiong WC; Mei L
J Biol Chem; 2001 Jun; 276(22):19318-26. PubMed ID: 11279080
[TBL] [Abstract][Full Text] [Related]
10. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity.
Kuang X; Salinger A; Benavides F; Muller WJ; Dent SYR; Koutelou E
PLoS One; 2024; 19(1):e0290837. PubMed ID: 38236941
[TBL] [Abstract][Full Text] [Related]
11. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
12. Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.
Floris A; Luo J; Frank J; Zhou J; Orrù S; Biancolella M; Pucci S; Orlandi A; Campagna P; Balzano A; Ramani K; Tomasi ML
J Exp Clin Cancer Res; 2019 Jan; 38(1):4. PubMed ID: 30611309
[TBL] [Abstract][Full Text] [Related]
13. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
Boulay PL; Mitchell L; Turpin J; Huot-Marchand JÉ; Lavoie C; Sanguin-Gendreau V; Jones L; Mitra S; Livingstone JM; Campbell S; Hallett M; Mills GB; Park M; Chodosh L; Strathdee D; Norman JC; Muller WJ
Cancer Res; 2016 May; 76(9):2662-74. PubMed ID: 26933086
[TBL] [Abstract][Full Text] [Related]
14. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
15. Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation.
Raven JF; Williams V; Wang S; Tremblay ML; Muller WJ; Durbin JE; Koromilas AE
Cell Cycle; 2011 Mar; 10(5):794-804. PubMed ID: 21311224
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers.
Raja SM; Clubb RJ; Ortega-Cava C; Williams SH; Bailey TA; Duan L; Zhao X; Reddi AL; Nyong AM; Natarajan A; Band V; Band H
Cancer Biol Ther; 2011 Jan; 11(2):263-76. PubMed ID: 21088503
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
[TBL] [Abstract][Full Text] [Related]
18. Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis.
Xi C; Hu Y; Buckhaults P; Moskophidis D; Mivechi NF
J Biol Chem; 2012 Oct; 287(42):35646-35657. PubMed ID: 22847003
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma.
Wu H; Yao S; Zhang S; Wang JR; Guo PD; Li XM; Gan WJ; Mei L; Gao TM; Li JM
J Hepatol; 2017 Jun; 66(6):1193-1204. PubMed ID: 28192186
[TBL] [Abstract][Full Text] [Related]
20. ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis.
Xu M; Ren Z; Wang X; Comer A; Frank JA; Ke ZJ; Huang Y; Zhang Z; Shi X; Wang S; Luo J
Mol Cancer; 2016 Jul; 15(1):52. PubMed ID: 27416801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
